annual accounts payable:
$309.55M+$51.18M(+19.81%)Summary
- As of today (June 7, 2025), RDY annual accounts payable is $309.55 million, with the most recent change of +$51.18 million (+19.81%) on March 1, 2025.
- During the last 3 years, RDY annual accounts payable has risen by +$98.93 million (+46.97%).
- RDY annual accounts payable is now at all-time high.
Performance
RDY Accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly accounts payable:
$309.55M-$110.35M(-26.28%)Summary
- As of today (June 7, 2025), RDY quarterly accounts payable is $309.55 million, with the most recent change of -$110.35 million (-26.28%) on March 1, 2025.
- Over the past year, RDY quarterly accounts payable has increased by +$51.18 million (+19.81%).
- RDY quarterly accounts payable is now -27.56% below its all-time high of $427.34 million, reached on September 30, 2024.
Performance
RDY quarterly accounts payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Accounts payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
RDY Accounts payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.8% | +19.8% |
| 3 y3 years | +47.0% | +47.0% |
| 5 y5 years | +117.3% | +117.3% |
RDY Accounts payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +47.0% | -27.6% | +47.0% |
| 5 y | 5-year | at high | +117.3% | -27.6% | +117.3% |
| alltime | all time | at high | +1998.6% | -27.6% | +1433.9% |
RDY Accounts payable History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | $309.55M(+19.8%) | $309.55M(-26.3%) |
| Dec 2024 | - | $419.91M(-1.7%) |
| Sep 2024 | - | $427.34M(+4.6%) |
| Jun 2024 | - | $408.73M(+58.2%) |
| Mar 2024 | $258.37M(+18.8%) | $258.37M(-30.7%) |
| Dec 2023 | - | $372.70M(+1.7%) |
| Sep 2023 | - | $366.37M(+8.6%) |
| Jun 2023 | - | $337.28M(+55.1%) |
| Mar 2023 | $217.50M(+3.3%) | $217.50M(-30.8%) |
| Dec 2022 | - | $314.44M(+12.5%) |
| Sep 2022 | - | $279.55M(-12.0%) |
| Jun 2022 | - | $317.51M(+50.7%) |
| Mar 2022 | $210.63M(+21.9%) | $210.63M(-36.0%) |
| Dec 2021 | - | $329.05M(-4.3%) |
| Sep 2021 | - | $343.80M(-10.7%) |
| Jun 2021 | - | $385.08M(+122.8%) |
| Mar 2021 | $172.86M(+21.3%) | $172.86M(-45.0%) |
| Dec 2020 | - | $314.13M(+1.9%) |
| Sep 2020 | - | $308.18M(+22.6%) |
| Jun 2020 | - | $251.34M(+76.4%) |
| Mar 2020 | $142.47M(-3.9%) | $142.47M(-42.8%) |
| Dec 2019 | - | $248.89M(+13.7%) |
| Sep 2019 | - | $218.87M(+2.3%) |
| Jun 2019 | - | $214.04M(+44.4%) |
| Mar 2019 | $148.25M(+4.8%) | $148.25M(-34.9%) |
| Dec 2018 | - | $227.88M(+17.4%) |
| Sep 2018 | - | $194.05M(-9.9%) |
| Jun 2018 | - | $215.28M(+52.2%) |
| Mar 2018 | $141.43M | $141.43M(-38.0%) |
| Dec 2017 | - | $228.24M(+5.1%) |
| Sep 2017 | - | $217.15M(+6.4%) |
| Jun 2017 | - | $204.06M(+4.2%) |
| Dec 2016 | - | $195.89M(+6.6%) |
| Sep 2016 | - | $183.72M(-2.6%) |
| Jun 2016 | - | $188.68M(+6.0%) |
| Dec 2015 | - | $177.97M(-8.1%) |
| Sep 2015 | - | $193.66M(+7.8%) |
| Jun 2015 | - | $179.62M(-7.6%) |
| Dec 2014 | - | $194.49M(-6.8%) |
| Sep 2014 | - | $208.57M(+17.7%) |
| Jun 2014 | - | $177.16M(+12.4%) |
| Dec 2013 | - | $157.66M(-8.4%) |
| Sep 2013 | - | $172.06M(+2.8%) |
| Jun 2013 | - | $167.36M(-16.6%) |
| Dec 2012 | - | $200.79M(+2.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2012 | - | $196.37M(+27.5%) |
| Jun 2012 | - | $154.00M(-11.1%) |
| Dec 2011 | - | $173.21M(-5.3%) |
| Sep 2011 | - | $182.82M(-2.8%) |
| Jun 2011 | - | $188.14M(-1.0%) |
| Mar 2011 | $189.95M(-8.6%) | $189.95M(+15.2%) |
| Dec 2010 | - | $164.91M(-25.5%) |
| Sep 2010 | - | $221.42M(+6.2%) |
| Jun 2010 | - | $208.51M(+0.3%) |
| Mar 2010 | $207.79M(+75.9%) | $207.79M(+63.1%) |
| Dec 2009 | - | $127.39M(-15.3%) |
| Sep 2009 | - | $150.44M(+4.5%) |
| Jun 2009 | - | $143.92M(+21.8%) |
| Mar 2009 | $118.12M(-12.7%) | $118.12M(-15.4%) |
| Dec 2008 | - | $139.63M(-20.8%) |
| Sep 2008 | - | $176.26M(-2.3%) |
| Jun 2008 | - | $180.40M(+33.3%) |
| Mar 2008 | $135.30M(+22.2%) | $135.30M(+0.0%) |
| Dec 2007 | - | $135.28M(-9.9%) |
| Sep 2007 | - | $150.21M(+14.5%) |
| Jun 2007 | - | $131.21M(+18.5%) |
| Mar 2007 | $110.73M(+35.1%) | $110.73M(-13.9%) |
| Dec 2006 | - | $128.60M(-38.7%) |
| Sep 2006 | - | $209.65M(+24.2%) |
| Jun 2006 | - | $168.86M(+106.1%) |
| Mar 2006 | $81.94M(+152.4%) | $81.94M(+71.5%) |
| Dec 2005 | - | $47.78M(+11.9%) |
| Sep 2005 | - | $42.72M(+1.0%) |
| Jun 2005 | - | $42.30M(+30.3%) |
| Mar 2005 | $32.46M(-35.4%) | $32.46M(-12.0%) |
| Dec 2004 | - | $36.89M(-25.2%) |
| Sep 2004 | - | $49.31M(+0.2%) |
| Jun 2004 | - | $49.22M(-2.1%) |
| Mar 2004 | $50.28M(+44.7%) | $50.28M(+8.8%) |
| Dec 2003 | - | $46.24M(-2.5%) |
| Sep 2003 | - | $47.40M(+8.0%) |
| Jun 2003 | - | $43.91M(+26.4%) |
| Mar 2003 | $34.75M(+51.0%) | $34.75M(+2.8%) |
| Dec 2002 | - | $33.81M(+8.1%) |
| Sep 2002 | - | $31.27M(-1.9%) |
| Jun 2002 | - | $31.89M(+38.6%) |
| Mar 2002 | $23.01M(+56.0%) | $23.01M(+5.5%) |
| Dec 2001 | - | $21.82M(+8.1%) |
| Sep 2001 | - | $20.18M(-30.2%) |
| Jun 2001 | - | $28.91M |
| Mar 2001 | $14.75M | - |
FAQ
- What is Dr Reddys Laboratories Limited annual accounts payable?
- What is the all time high annual accounts payable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited annual accounts payable year-on-year change?
- What is Dr Reddys Laboratories Limited quarterly accounts payable?
- What is the all time high quarterly accounts payable for Dr Reddys Laboratories Limited?
- What is Dr Reddys Laboratories Limited quarterly accounts payable year-on-year change?
What is Dr Reddys Laboratories Limited annual accounts payable?
The current annual accounts payable of RDY is $309.55M
What is the all time high annual accounts payable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high annual accounts payable is $309.55M
What is Dr Reddys Laboratories Limited annual accounts payable year-on-year change?
Over the past year, RDY annual accounts payable has changed by +$51.18M (+19.81%)
What is Dr Reddys Laboratories Limited quarterly accounts payable?
The current quarterly accounts payable of RDY is $309.55M
What is the all time high quarterly accounts payable for Dr Reddys Laboratories Limited?
Dr Reddys Laboratories Limited all-time high quarterly accounts payable is $427.34M
What is Dr Reddys Laboratories Limited quarterly accounts payable year-on-year change?
Over the past year, RDY quarterly accounts payable has changed by +$51.18M (+19.81%)